Infusion device and methods

Patent metadata

Field	Value
Publication number	US-12073941-B2
Application number	US-202217984524-A
Country	US
Kind code	B2
Filing date	Nov 10, 2022
Priority date	Oct 31, 2006
Publication date	Aug 27, 2024
Grant date	Aug 27, 2024

Abstract

Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.

First claim

The invention claimed is:

1. A computing device in data communication with a skin-mounted assembly comprising an in vivo glucose sensor and a transmitter unit, the computing device comprising:
one or more processors;
one or more memory units operatively coupled to the one or more processors and including program instructions stored therein which, when executed by the one or more processors, causes the one or more processors to:
receive, via user input, individual hierarchical access level rights including at least first access level rights and second access level rights, wherein the first access level rights enable a first individual to view first level parameters of a plurality of parameters of the computing device, and wherein the second access level rights enable a second individual to view second level parameters of the plurality of parameters using the computing device, the second level parameters at least being different than the first level parameters, wherein the first level parameters and the second level parameters relate to data indicative of a glucose level, the data received from the skin-mounted assembly;
transmit the first access level rights to a data management system, wherein the first access level rights are associated with a first device associated with the first individual; and
transmit the second access level rights to the data management system, wherein the second access level rights are associated with a second device associated with the second individual;
receive, from the skin-mounted assembly, the data indicative of the glucose level; and
transmit the data indicative of the glucose level to the data management system,
wherein the first access level rights are configured to cause the data management system to transmit a notification including the data indicative of the glucose level to the first device.

2. The computing device of claim 1 , wherein the computing device receives the data indicative of the glucose level from the in vivo glucose sensor via the transmitter unit.

3. The computing device of claim 2 , wherein the in vivo glucose sensor is an in vivo continuous glucose sensor.

4. The computing device of claim 1 , wherein the first level parameters comprises a first visual representation of the data indicative of the glucose level from the computing device and the second level parameters comprises a second visual representation of the data indicative of the glucose level from the computing device, wherein the first visual representation is different from the second visual representation.

5. The computing device of claim 4 , wherein the first visual representation of the data indicative of the glucose level comprises a first glucose trend chart and the second visual representation of the data indicative of the glucose level comprise a second trend chart.

6. The computing device of claim 1 , wherein the first access level rights enable the first individual to modify, set, or lock first level parameters of the plurality of parameters of the computing device, and wherein the first level parameters include at least prescriptive parameters.

7. The computing device of claim 6 , wherein the prescriptive parameters include one or more of a basal rate, a target analyte range, an alert or alarm threshold, a medication type, a medication dose, a total daily medication dose, a drug sensitivity, a parameter associated with when to take medication, a parameter associated with how to take medication, a parameter associated with when to treat a health condition, a parameter associated with how to treat the health condition, and a reminder scheme.

8. The computing device of claim 1 , wherein the second access level rights enable the second individual to set, modify, or lock the second level parameters of the plurality of parameters using the computing device, the second level parameters at least being different than first level parameters locked by the first individual, and wherein the second level parameters include at least non-prescriptive parameters.

9. The computing device of claim 8 , wherein the non-prescriptive parameters include one or more of an alarm value, a user menu access parameter, a data transfer and storage parameter, and a reminder associated therewith.

10. The computing device of claim 8 , wherein the second level parameters further include prescriptive parameters that have not been locked by the first individual.

11. A method performed by a computing device in data communication with a skin-mounted assembly comprising an in vivo glucose sensor and a transmitter unit, the method comprising:
configuring a computing device with an access level hierarchy to provide individual hierarchical access level rights including at least first access level rights and second access level rights, wherein the first access level rights enable a first individual to view first level parameters of a plurality of parameters of the computing device, and wherein the second access level rights enable a second individual to view second level parameters of the plurality of parameters using the computing device, the second level parameters at least being different than the first level parameters, wherein the first level parameters and the second level parameters relate to data indicative of a glucose level, the data received from the skin-mounted assembly;
transmitting the first access level rights to a data management system, wherein the first access level rights are associated with a first device associated with the first individual;
transmitting the second access level rights to the data management system, wherein the second access level rights are associated with a second device associated with the second individual;
receiving, from the skin-mounted assembly, the data indicative of the glucose level; and
transmitting the data indicative of the glucose level to the data management system,
wherein the first access level rights are configured to cause the data management system to transmit a notification including the data indicative of the glucose level to the first device.

12. The method of claim 11 , further comprising configuring the computing device to be in data communication with an in vivo analyte sensor.

13. The method of claim 12 , wherein the in vivo analyte sensor is an in vivo continuous glucose sensor.

14. The method of claim 11 , wherein the first level parameters comprises a first visual representation of the data indicative of the glucose level from the computing device and the second level parameters comprises a second visual representation of the data indicative of the glucose level from the computing device, wherein the first visual representation is different from the second visual representation.

15. The method of claim 14 , wherein the first visual representation of the data indicative of the glucose level comprises a first glucose trend chart and the second visual representation of the data indicative of the glucose level comprise a second trend chart.

16. The method of claim 14 , wherein the first level parameters include at least prescriptive parameters.

17. The method of claim 16 , wherein the prescriptive parameters include one or more of a basal rate, a target analyte range, an alert or alarm threshold, a medication type, a medication dose, a total daily medication dose, a drug sensitivity, a parameter associated with when to take mediation, a parameter associated with how to take medication, a parameter associated with when to treat a health condition, a parameter associated with how to treat the health condition, and a reminder scheme.

Assignees

• Abbott Diabetes Care Inc

Inventors

• Reggiardo Christopher V
• Kiaie Namvar
• Thomson James

Classifications

• G16H20/17

  delivered via infusion or injection · CPC title

• G06F21/30

  Authentication, i.e. establishing the identity or authorisation of security principals · CPC title

• A61M5/1723

  using feedback of body parameters, e.g. blood-sugar, pressure (measurement of body parameters A61B5/00) · CPC title

• G06F21/44

  Program or device authentication · CPC title

• H04L63/105

  Multiple levels of security · CPC title